A Scottish life sciences company specialising in the development of
bioinformatics software has been sold to QbioCom, a rival firm
based in England, for £1 million.
In 2003, Freeman Technology launched its new-generation FT4
rheometer in Europe for testing the flow properties of powders, an
important measurement in the pharmaceutical and chemical industries
where most processes involve the extensive...
Cambrex has appointed a new CEO to oversee the combination of its
small-molecule and biological active pharmaceutical ingredient
(API) activities into a single business unit.
Agilent returns to profit for the first time in two years in the
fourth quarter ended October 31, as cost-cutting compensated for a
modest decline in revenues.
The healthcare division of UK-based speciality chemicals maker
Croda Chemicals Europe used the CPhI exhibition in Frankfurt this
week as a platform to launch two new excipients for drug delivery.
The market for protein and DNA purification kits is maturing, and
the pace of technological innovation has slowed, leaving dozens of
companies jostling for market share.
Cardinal Health posted higher earnings in the first quarter of
fiscal 2004, on the back of increased demand in its prescription
drug wholesale business but also some impressive gains at its
pharmaceutical technologies activities....
Sartorius North America and KMI/Parexel International have formed
an alliance that will improve the geographic reach of their
biopharmaceutical production and consultancy services.
Millipore has reported a hike in third quarter sales and profits on
the back of a revival in the biotechnology industry's fortunes, but
said this may not last to the end of the year.
Sweden's Pyrosequencing has entered into an agreement to buy
prification and separation specialist Biotage, a subsidiary of Dyax
of the USA, for $35 million.
Process manufacturing industries are not responding to a clear need
to improve the information flow between the different parts of
their businesses leading to costly plant shutdowns, says a new
survey commissioned by BASF IT Services.
Tepnel Life Sciences has trimmed its losses and boosted sales in
the year ended 30 June, helped by the sale last month of its first
robotic Nucleopure DNA purification systems.
Capsule technology company BioProgress has reported its first set
of interim results since becoming an AIM-listed company, as well as
a distribution deal with Hoefliger.
Pall has reported a 10 per cent rise in sales to $471 million
(€430m) in the fourth quarter, boosted by currencies and the
recently-acquired FSG operations.
Gradipore has reported a 65 per cent increase in sales for the year
ended 30 June, but said that it was disappointed by the figures,
which did not meet its expectations.
The US FTC has taken issue with the merger between Aspen Technology
and Hyprotech in 2002, alleging that it gave the combined firm a
too-dominant position in process control software.
Argonaut sells its HPLC business to Grace Vydac as it refocuses on
supplying consumables for companies working on drug discovery.
Reports reduced losses in first half.
Whatman has decided to wind down the operations of its German
subsidiary Biometra, taking a £10.1 million charge in the process.
The move fends off a patent infringement challenge from Applied
Biosystems.
Just over a year after acquiring the FSG business from Vivendi for
$360 million (€307m), Pall Corp has reported a healthy hike in
fiscal third-quarter sales and profits and once again raised its
earnings forecast for 2003.
Millipore, which specialises in providing technologies, tools and
services for the discovery, development and production of new
therapeutic drugs, has reported first-quarter 2003 sales of $187
million (€173 million), up 13 per cent...
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
Indena offers custom development by leveraging the expertise of a specialized team devoted to designing and developing processes and analytical methods....
